<DOC>
	<DOCNO>NCT01375387</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetics lacosamide follow single oral administration lacosamide 100 mg , 200 mg 400 mg healthy male Chinese Japanese subject .</brief_summary>
	<brief_title>Three-way-cross-over Study Evaluate Safety Pharmacokinetics Lacosamide Healthy Japanese Chinese Males</brief_title>
	<detailed_description />
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Healthy Chinese Japanese volunteer Subject participate participate clinical study Lacosamide within last 3 month Subject healthy ( eg , take drug treatment , excessive amount alcohol , cigarettes caffeine , psychological emotional problem , drug/alcohol abuse , abnormal diet , abnormal safety parameter )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Vimpat</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy Japanese male</keyword>
	<keyword>Healthy Chinese male</keyword>
</DOC>